Linked Life Data

16750059

Source:http://linkedlifedata.com/resource/pubmed/id/16750059

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
2006-6-5
pubmed:abstractText
To determine whether combined therapy with interferon-alpha and ribavirin was more effective and cost-effective than no treatment for patients with mild chronic hepatitis C.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1366-5278
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-113, iii
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16750059-Adult, pubmed-meshheading:16750059-Analysis of Variance, pubmed-meshheading:16750059-Antiviral Agents, pubmed-meshheading:16750059-Cost of Illness, pubmed-meshheading:16750059-Cost-Benefit Analysis, pubmed-meshheading:16750059-Drug Therapy, Combination, pubmed-meshheading:16750059-Female, pubmed-meshheading:16750059-Genotype, pubmed-meshheading:16750059-Great Britain, pubmed-meshheading:16750059-Hepacivirus, pubmed-meshheading:16750059-Hepatitis C, Chronic, pubmed-meshheading:16750059-Humans, pubmed-meshheading:16750059-Interferon-alpha, pubmed-meshheading:16750059-Male, pubmed-meshheading:16750059-Polyethylene Glycols, pubmed-meshheading:16750059-Quality of Life, pubmed-meshheading:16750059-Quality-Adjusted Life Years, pubmed-meshheading:16750059-Questionnaires, pubmed-meshheading:16750059-Recombinant Proteins, pubmed-meshheading:16750059-Ribavirin, pubmed-meshheading:16750059-Treatment Outcome, pubmed-meshheading:16750059-Viral Load
pubmed:year
2006
pubmed:articleTitle
Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation.
pubmed:affiliation
Department of Medicine, St Mary's Hospital, London, UK.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Multicenter Study